Organization
Rheumatology, Great Lakes Clinical Trials, Chicago, United States of America
1 abstract
Abstract
A COMPARATIVE ANALYSIS OF UPADACITINIB MONOTHERAPY AND UPADACITINIB COMBINATION THERAPY FOR THE TREATMENT OF RHEUMATOID ARTHRITIS FROM TWO PHASE 3 TRIALSOrg: University of Leeds & NIHR Biomedical Research Centre, Leeds, United Kingdom, Rheumatology and Immunotherapy Center, Franklin, United States of America, Kantonsspital St Gallen, St Gallen, Switzerland, Rheumatology, Great Lakes Clinical Trials, Chicago, United States of America, AbbVie Inc., North Chicago, United States of America,